The Bladder Cancer Advocacy Network has announced its fall series of webinars, featuring bladder cancer experts on a variety of topics. The webinars are relevant to people with bladder cancer, caregivers, family, and friends:
The Bladder Cancer Advocacy Network has announced its fall series of webinars, featuring bladder cancer experts on a variety of topics. The webinars are relevant to people with bladder cancer, caregivers, family, and friends:
The New Normal After Bladder Removal Surgery: Part 2
Tuesday, October 21, 8-9 PM EDT
Presented by:
Tracy M. Downs, MD
Associate Professor, Urology
Director, Bladder Cancer and Intravesicle Programs
University of Wisconsin
Deborah Hensley, BSN, RN, CURN
Department of Urology
UT Southwestern Medical Center
Topics for this webinar include: recovery and what to expect after bladder removal surgery; preventing complications; deciding on a diversion, and recognizing what’s normal after surgery.
Click here to register.
What do you wish you had known before bladder removal surgery?
Tuesday, November 4, 8 PM EST
Presented by:
Jonathan L Wright, MD, MS, FACS
Department of Urology,
University of Washington School of Medicine,
Seattle Cancer Care Alliance
Topics for this webinar include: different urinary diversions and information from survivors on what they wish they had known before bladder surgery.
Click here to register.
Bladder Cancer Tests, Diagnosis & Screening
Thursday, November 13, 8 PM ET
Presented by:
Yair Lotan, MD
Holder of the Helen J. and Robert S. Strauss
Professorship in Urology
UT Southwestern Medical Center
Topics for this webinar include: what patients should know about tests used to diagnose and check for recurrence of bladder cancer and follow up and surveillance recommendations.
For more information, call 301-215-9099 or email: webinars@bcan.org
Key Advances in Cancer Survivorship Toxicity Management
July 15th 2022In this episode of The Vitals, Lidia Schapira, MD, FASCO, recounts highlights from the 2022 ASCO Symptoms and Survivorship track and underscores key takeaways for practitioners seeking to enhance the delivery of cancer survivorship care.
Enfortumab Vedotin Plus Pembrolizumab Improves Outcomes vs Chemo in Urothelial Cancer
April 20th 2024Patients with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin plus pembrolizumab experienced a reduction in the risk for disease progression or death vs chemotherapy.